当前位置:首页 - 行情中心 - 万邦医药(301520) - 财务分析 - 现金流量表

万邦医药

(301520)

  

流通市值:9.24亿  总市值:27.46亿
流通股本:2242.30万   总股本:6666.67万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金206,392,917.39136,319,130.9454,788,730353,144,573.08
  客户存款和同业存放款项净增加额-000
  向中央银行借款净增加额-000
  向其他金融机构拆入资金净增加额-000
  收到原保险合同保费取得的现金-000
  收到再保险业务现金净额-000
  保户储金及投资款净增加额-000
  收取利息、手续费及佣金的现金-000
  拆入资金净增加额-000
  回购业务资金净增加额-000
  收到的税费返还3,374,672.253,374,672.2500
  收到其他与经营活动有关的现金11,195,235.978,555,296.14671,626.3812,026,352.7
  经营活动现金流入的其他项目-000
  经营活动现金流入小计220,962,825.61148,249,099.3355,460,356.38365,170,925.78
  购买商品、接受劳务支付的现金137,163,132.8576,370,804.4635,783,122.89193,064,356.88
  客户贷款及垫款净增加额-000
  存放中央银行和同业款项净增加额-000
  支付原保险合同赔付款项的现金-000
  支付利息、手续费及佣金的现金-000
  支付保单红利的现金-000
  支付给职工以及为职工支付的现金54,721,999.0641,626,814.6628,132,556.2978,543,969.57
  支付的各项税费5,315,271.124,360,0061,505,623.8511,641,977.32
  支付其他与经营活动有关的现金17,403,026.1213,352,505.066,907,538.9435,079,138.26
  经营活动现金流出的其他项目-000
  经营活动现金流出小计214,603,429.15135,710,130.1872,328,841.97318,329,442.03
  经营活动产生的现金流量净额6,359,396.4612,538,969.15-16,868,485.5946,841,483.75
二、投资活动产生的现金流量:
  收回投资收到的现金1,232,768,589.54804,925,497.74684,925,497.741,163,334,122.71
  取得投资收益收到的现金12,918,535.666,645,443.35,980,265.2221,155,289.99
  处置固定资产、无形资产和其他长期资产收回的现金净额00093,064.6
  投资活动现金流入小计1,245,687,125.2811,570,941.04690,905,762.961,184,582,477.3
  购建固定资产、无形资产和其他长期资产支付的现金27,901,575.6518,034,5999,160,335.3741,822,829.25
  投资支付的现金1,308,204,967.75878,767,842.1665,552,167.111,229,820,463.86
  投资活动现金流出小计1,336,106,543.4896,802,441.1674,712,502.481,271,643,293.11
  投资活动产生的现金流量净额-90,419,418.2-85,231,500.0616,193,260.48-87,060,815.81
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金21,893,285.1321,893,285.1321,893,285.1331,144,610.88
  支付其他与筹资活动有关的现金12,394,84212,394,8424,902,0282,838,596
  筹资活动现金流出小计34,288,127.1334,288,127.1326,795,313.1333,983,206.88
  筹资活动产生的现金流量净额-34,288,127.13-34,288,127.13-26,795,313.13-33,983,206.88
五、现金及现金等价物净增加额-118,348,148.87-106,980,658.04-27,470,538.24-74,202,538.94
  加:期初现金及现金等价物余额179,294,435.57179,294,435.57179,294,435.57253,496,974.51
  期末现金及现金等价物余额60,946,286.772,313,777.53151,823,897.33179,294,435.57
补充资料:
  净利润-26,811,405.38-85,530,677.51
  资产减值准备-2,380,253.25-5,820,047.33
  固定资产和投资性房地产折旧-7,778,105.95-14,048,286.67
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-7,778,105.95-14,048,286.67
  无形资产摊销-540,828.76-1,071,564.05
  长期待摊费用摊销-1,935,182.59-3,859,446.18
  处置固定资产、无形资产和其他长期资产的损失-0--16,439.76
  固定资产报废损失---38,418.62
  公允价值变动损失--11,515,386.15--7,034,391.6
  财务费用---0
  投资损失--2,638,364.11--21,155,290.01
  递延所得税--2,020,736.99-1,326,199.81
  其中:递延所得税资产减少--345,337.48-113,037.38
    递延所得税负债增加--1,675,399.51-1,213,162.43
  存货的减少-976,231.02--1,293,690.64
  经营性应收项目的减少--6,986,528.08--48,761,361.92
  经营性应付项目的增加--4,722,022.47-13,408,017.51
  现金的期末余额-72,313,777.53-179,294,435.57
  减:现金的期初余额-179,294,435.57-253,496,974.51
  现金及现金等价物的净增加额--106,980,658.04--74,202,538.94
公告日期2025-10-232025-08-262025-04-222025-04-22
审计意见(境内)标准无保留意见
TOP↑